Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Verastem Inc (NASDAQ:VSTM)

1.13
Delayed Data
As of Feb 05
 -0.06 / -5.04%
Today’s Change
1.07
Today|||52-Week Range
12.35
-39.25%
Year-to-Date
No recent news for Verastem Inc.

Today’s Trading

Previous close1.19
Today’s open1.15
Day’s range1.13 - 1.19
Volume252,584
Average volume (3 months)789,557
Market cap$41.7M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-13.74%
Earnings growth (this year)+20.83%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.35

Competitors

 Today’s
change
Today’s
% change
ORPNBio Blast Pharma Ltd+0.02+0.66%
QUREUniqure NV-1.08-6.52%
VBIVVBI Vaccines Inc-0.16-7.55%
STEMStemCells Inc-0.01-2.08%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$0.00
Annual profit (last year)-$53.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert M. Forrester
Chief Operating Officer
Daniel W. Paterson
Corporate headquarters
Needham, Massachusetts

Forecasts

Partner Offers